0001753926-24-001445.txt : 20240815 0001753926-24-001445.hdr.sgml : 20240815 20240814185829 ACCESSION NUMBER: 0001753926-24-001445 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240815 DATE AS OF CHANGE: 20240814 EFFECTIVENESS DATE: 20240815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LIPELLA PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001347242 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-521579 FILM NUMBER: 241210098 BUSINESS ADDRESS: STREET 1: 400 N LEXINGTON ST STREET 2: STE LL103 CITY: PITTSBURGH STATE: PA ZIP: 15208 BUSINESS PHONE: 412-901-0315 MAIL ADDRESS: STREET 1: 400 N LEXINGTON ST STREET 2: STE LL103 CITY: PITTSBURGH STATE: PA ZIP: 15208 FORMER COMPANY: FORMER CONFORMED NAME: LIPELLA PHARMACEUTICALS INC DATE OF NAME CHANGE: 20051219 D 1 primary_doc.xml X0708 D LIVE 0001347242 LIPELLA PHARMACEUTICALS INC. 7800 SUSQUEHANNA ST. SUITE 505 PITTSBURGH PA PENNSYLVANIA 15208 (412) 894-1853 DELAWARE None LIPELLA PHARMACEUTICALS INC Corporation true Jonathan Kaufman 7800 Susquehanna St. Suite 505 Pittsburgh PA PENNSYLVANIA 15208 Executive Officer Director President, Chief Executive Officer, Secretary, Treasurer and Chairman of the Board of Directors Michael Chancellor 7800 Susquehanna St. Suite 505 Pittsburgh PA PENNSYLVANIA 15208 Executive Officer Director Chief Medical Officer Douglas Johnston 7800 Susquehanna St. Suite 505 Pittsburgh PA PENNSYLVANIA 15208 Executive Officer Chief Financial Officer Lori Birder 7800 Susquehanna St. Suite 505 Pittsburgh PA PENNSYLVANIA 15208 Director Ryan Pruchnic 7800 Susquehanna St. Suite 505 Pittsburgh PA PENNSYLVANIA 15208 Director Daniel Cohen 7800 Susquehanna St. Suite 505 Pittsburgh PA PENNSYLVANIA 15208 Director Byong Kim 7800 Susquehanna St. Suite 505 Pittsburgh PA PENNSYLVANIA 15208 Director Naoki Yoshimura 7800 Susquehanna Street Suite 505 Pittsburgh PA PENNSYLVANIA 15208 Director Pharmaceuticals Decline to Disclose 06b false 2024-07-31 false true true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 Park Ave 4th Floor New York NY NEW YORK 10022 NY NEW YORK false 120086 120086 0 Represents warrants issued to H.C. Wainwright & Co., LLC to purchase up to 154,950 shares of common stock at $0.775 per share, in connection with an offering by the issuer as disclosed in the issuer's Form 8-K filed with the SEC on August 1, 2024. false 1 0 0 In connection with the issuer's August 1, 2024 registered offering, H.C. Wainwright & Co., LLC received approximate fees of $96,069 as a commission, $12,809 as a management fee, $45,000 in reimbursements and the placement agent warrants. 0 false LIPELLA PHARMACEUTICALS INC. /s/ Jonathan Kaufman Jonathan Kaufman President and Chief Executive Officer 2024-08-14